Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 5 of 5 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/31/15
End: 04/30/16
Due: 04/30/17
Phase: N/A
Priority: Normal
Start: 04/20/18
End: 03/15/20
Due: 03/15/21
Phase: N/A
Priority: Normal
Start: 01/01/20
End: 08/30/20
Due: 08/30/21
Phase: N/A
Priority: Normal
Start: 01/11/21
End: 12/30/22
Due: 12/30/23
Phase: N/A
Priority: Normal
Start: 08/08/18
End: 07/05/19
Due: 07/05/20
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| VIveve Treatment of the Vaginal Introitus to EValuate Effectiveness | NCT02261974 | Viveve Inc. | user2@example.com | None | 2015-01-31 | 2016-04-30 | 2017-04-30 | - | - | 2025-07-14 |
| Viveve Geneveve Treatment of the Vaginal Introitus to Evaluate Safety and Efficacy | NCT03479229 | Viveve Inc. | user2@example.com | None | 2018-04-20 | 2020-03-15 | 2021-03-15 | - | - | 2025-07-14 |
| Comparison of the Viveve Treatment and Cryogen-Only Treatment Versus Sham Treatment for Stress Urinary Incontinence | NCT04206085 | Viveve Inc. | user2@example.com | None | 2020-01-01 | 2020-08-30 | 2021-08-30 | - | - | 2025-07-14 |
| Prospective US Radiofrequency SUI Trial | NCT04720352 | Viveve Inc. | user2@example.com | None | 2021-01-11 | 2022-12-30 | 2023-12-30 | - | - | 2025-07-14 |
| LIBERATE International | NCT03619174 | Viveve Inc. | user2@example.com | None | 2018-08-08 | 2019-07-05 | 2020-07-05 | - | - | 2025-07-14 |